Skip to Main Content

Author Details

Yuexin Liu
The University of Texas MD Anderson Cancer Center
2011
51
28
PMIDPaper TitleJournal TitlePublished Year
36930815Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.Cancer2023
37627071Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images.Cancers (Basel)2023
36930815Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.Cancer2023
37627071Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images.Cancers (Basel)2023
31702382LncRNA LINC00974 Downregulates miR-122 to Upregulate RhoA in Oral Squamous Cell Carcinoma.Cancer Biother Radiopharm2021
31702382LncRNA LINC00974 Downregulates miR-122 to Upregulate RhoA in Oral Squamous Cell Carcinoma.Cancer Biother Radiopharm2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
34907910Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.J Clin Invest2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
34907910Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.J Clin Invest2021
32405341Clinical implications of chromatin accessibility in human cancers.Oncotarget2020
31730714Pan-cancer clinical and molecular analysis of racial disparities.Cancer2020
32405341Clinical implications of chromatin accessibility in human cancers.Oncotarget2020
31730714Pan-cancer clinical and molecular analysis of racial disparities.Cancer2020
30847026Immune response characterization of endometrial cancer.Oncotarget2019
31645905Clinicopathological correlation of immune response in human cancers.Oncotarget2019
31839882Survival correlation of immune response in human cancers.Oncotarget2019
31929987Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.Hepatobiliary Surg Nutr2019
31509758Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
31433971The Immune Landscape of Cancer.Immunity2019
30956779A global immune gene expression signature for human cancers.Oncotarget2019
30847026Immune response characterization of endometrial cancer.Oncotarget2019
31365877Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
31106233ZC3H12A Expression in Different Stages of Colorectal Cancer.Oncoscience2019
31645905Clinicopathological correlation of immune response in human cancers.Oncotarget2019
31929987Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.Hepatobiliary Surg Nutr2019
31839882Survival correlation of immune response in human cancers.Oncotarget2019
31433971The Immune Landscape of Cancer.Immunity2019
31509758Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
31365877Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
30956779A global immune gene expression signature for human cancers.Oncotarget2019
31106233ZC3H12A Expression in Different Stages of Colorectal Cancer.Oncoscience2019
29731976Predicting high-risk endometrioid carcinomas using proteins.Oncotarget2018
30268436A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.Cell Syst2018
30064493Clinical significance of FBXO17 gene expression in high-grade glioma.BMC Cancer2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29617664Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Cell Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29596783Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.Cell Syst2018
29731976Predicting high-risk endometrioid carcinomas using proteins.Oncotarget2018
30064493Clinical significance of FBXO17 gene expression in high-grade glioma.BMC Cancer2018
30268436A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.Cell Syst2018
29617664Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Cell Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29596783Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.Cell Syst2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
27876675A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer.J Thorac Oncol2017
28985752Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.J Hematol Oncol2017
28528867A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.Cancer Cell2017
27741356MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.J Pathol2017
  • 1 - 50 of 102

Recommended Authors

Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 5
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 9
University of Science and Technology Liaoning
Career Start Year 2009
Number of shared co-authors 3
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 5
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 2
University of Minnesota
Career Start Year 2008
Number of shared co-authors 11
University of Basel
Career Start Year 2008
Number of shared co-authors 4
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 10
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 7
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 10
College of Big Data & Software Engineering, Chongqing University
Career Start Year 2005
Number of shared co-authors 12
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 5
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 9
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 21
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 29
Peter MacCallum Cancer Centre
Career Start Year 2002
Number of shared co-authors 6
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 10
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 2
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 12
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 9
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 27
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 18
University of British Columbia
Career Start Year 1994
Number of shared co-authors 35
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 9
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 6

Collaborators

The University of Texas MD Anderson Cancer Center
Co-authored papers 16
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Institute for Systems Biology
Co-authored papers 9
Dana-Farber Cancer Institute
Co-authored papers 9
Aier Eye Hospital of Wuhan University
Co-authored papers 9
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 8
MD Anderson Cancer Center
Co-authored papers 7
Present address: Dxige Research Inc.
Co-authored papers 6
Van Andel Institute
Co-authored papers 6
University of California San Francisco
Co-authored papers 5
Van Andel Institute
Co-authored papers 5
The University of Western Australia
Co-authored papers 5
Harvard Medical School
Co-authored papers 5
Buck Institute for Research on Aging
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Co-authored papers 4
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 4
Perlmutter Cancer Center
Co-authored papers 4
University of Michigan-Ann Arbor
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
University of Alabama at Birmingham
Co-authored papers 3